Opioid Education and Prescribing Practices

References

1. 1.↵
   National Institute on Drug Abuse. The federal response to the opioid crisis. (2017). Available from: https://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2017/the-federal-response-to-the-opioid-crisis. Accessed November 20, 2020.
2. 2.↵
   1. Dowell D,
   2. Haegerich TM,
   3. Chou R

   . CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016. MMWR Recomm Rep 2016;65:1–49.

   OpenUrlCrossRefPubMed
3. 3.↵
   Centers for Disease Control Prevention. Training and Continuing Education (TCE) Online. Module 8: Implementing CDC's opioid prescribing guideline into clinical practice, 2020. Available from: https://www.cdc.gov/drugoverdose/training/implementing/.
4. 4.↵
   Centers for Disease Control Prevention. Training and Continuing Education (TCE) Online. Module 13: Using the Prescription Drug Monitoring Program to Promote Patient Safety in Opioid Prescribing and Dispensing, 2020. Available from: https://www.cdc.gov/drugoverdose/training/pdmp/index.html.
5. 5.↵
   Provider's Clinical Support System–Universities. Substance Abuse and Mental Health Services Administration, Provider's Clinical Support System–Universities, 2019. Available from: https://www.samhsa.gov/providers-clinical-support-system-universities.
6. 6.↵
   U.S. Food and Drug Administration (FDA). Format and Content of a REMS Document Guidance for Industry. Draft Guidance, 2017. Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM184128.pdf.
7. 7.↵
   1. Gottlieb S

   . Statement from FDA Commissioner Scott Gottlieb, MD, on National Academies of Sciences, Engineering, and Medicine report on pain management and prescription opioid abuse. FDA Statement, 2017. Available from: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm566958.htm.
8. 8.↵
   1. McCalmont JC,
   2. Jones KD,
   3. Bennett RM,
   4. Friend R

   . Does familiarity with CDC guidelines, continuing education, and provider characteristics influence adherence to chronic pain management practices and opioid prescribing? J Opioid Manag 2018;14:103–116.

   OpenUrl
9. 9.↵
   1. Ebbert JO,
   2. Philpot LM,
   3. Clements CM,
   4. et al

   . Attitudes, beliefs, practices, and concerns among clinicians prescribing opioids in a large academic institution. Pain Med 2018;19:1790–1798.

   OpenUrl
10. 10.↵
    1. Osborn SR,
    2. Yu J,
    3. Williams B,
    4. Vasilyadis M,
    5. Blackmore CC

    . Changes in provider prescribing patterns after implementation of an emergency department prescription opioid policy. J Emerg Med 2017;52:538–546.

    OpenUrlCrossRefPubMed
11. 11.↵
    The American Association for Public Opinion Research. Standard Definitions: Final 570 Dispositions of Case Codes and Outcome Rates for Surveys. 9th ed. 2016.
12. 12.↵
    1. Blackman K

    . Preventing Opioid Misuse: Legislative Trends and Predictions. National Conference of State Legislatures, 2017. Available from: https://www.ncsl.org/blog/2017/01/31/preventing-opioid-misuse-legislative-trends-and-predictions.aspx.
13. 13.↵
    1. Gupta A,
    2. Lindstrom S,
    3. Shevatekar G

    . Reducing opioid overprescribing by educating, monitoring and collaborating with clinicians: a quality improvement study. Cureus 2020;12:e7778.

    OpenUrl
14. 14.↵
    1. Levy B,
    2. Paulozzi L,
    3. Mack KA,
    4. et al

    . Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007– 2012. Am J Prev Med 2015;49:409–413.

    OpenUrlCrossRefPubMed